Biogen (BIIB) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…
Best AI Trading & Performance Tools

December 21, 2024 Best AI Trading & Performance Tools

Ever find yourself overwhelmed by the rapid twists and turns of the stock market? I know the feeling—one moment you’re riding high, and…
Best Economic Calendars For Traders

December 21, 2024 Best Economic Calendars For Traders

You know that feeling when a crucial financial announcement catches you off guard, and suddenly your trading plans are turned upside down? We’ve…
When to Switch Payroll Solutions and How to Make a Smooth Transition

December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition

Payroll solutions are important for every business, as without them, you cannot make the right choices and calculations in your payment system. However,…

Biogen (BIIB) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: January 19, 2025 (22:18)

Sector: Healthcare

The share price of Biogen Inc. (BIIB) now

Latest session on the 17th of January for
Biogen Inc. is negative
Trading Volume: 1150005
Open: 143.13 /  High: 143.5 /  Low: 140.061
Current value: $140.55
What analysts predict: $231.71
52-week High/Low: $252.17 / $140.05
50-Day Moving Average: $155.98 — resistance level today
200-Day Moving Average: $195.39 — resistance level today

Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2025, 2026, 2027. How much will one Biogen share be worth in 2025 - 2027?

When should I take profit in Biogen stock? When should I record a loss on Biogen stock? What are analysts' forecasts for Biogen stock? What is the future of Biogen stock? We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.


Historical and forecast chart of Biogen stock

The chart below shows the historical price of Biogen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.

Long-term forecasts by years.

Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.

The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.

Official site of the company

Trending Themes in the Healthcare Sector

Biogen daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 21 142.12 140.07 145.27 3.71
Jan 22 143.48 141.85 144.47 1.85
Jan 23 139.31 136.88 141.48 3.36
Jan 24 140.69 138.24 141.87 2.63
Jan 25 139.55 137.41 141.18 2.74
Jan 26 138.96 136.71 140.05 2.44
Jan 27 140.25 138.02 142.27 3.08
Jan 28 140.72 139.20 142.87 2.64
Jan 29 136.54 134.04 139.20 3.85
Jan 30 132.61 130.89 135.67 3.65
Jan 31 133.60 130.39 136.61 4.76
Feb 01 133.80 132.15 135.04 2.19
Feb 02 135.08 132.98 137.03 3.05
Feb 03 133.95 131.66 136.60 3.75
Feb 04 133.95 131.98 136.88 3.71
Feb 05 133.79 130.62 136.52 4.52
Feb 06 134.35 132.98 137.09 3.09
Feb 07 134.07 132.38 136.60 3.19
Feb 08 131.78 130.20 134.66 3.43
Feb 09 130.99 127.84 132.32 3.50
Feb 10 129.18 127.67 130.22 2.00
Feb 11 131.12 130.25 132.85 1.99
Feb 12 131.39 128.67 134.35 4.41
Feb 13 131.27 130.09 133.79 2.85
Feb 14 131.00 129.23 133.71 3.47
Feb 15 131.98 130.63 133.64 2.30
Feb 16 132.49 131.14 133.93 2.12
Feb 17 133.61 131.16 136.69 4.22
Feb 18 132.00 128.92 133.39 3.47
Feb 19 128.40 126.17 130.21 3.21

Biogen Daily Price Targets


Biogen Stock Forecast 01-21-2025.

Forecast target price for 01-21-2025: $142.12.
Positive dynamics for Biogen shares will prevail with possible volatility of 3.581%.
Pessimistic target level: 140.07
Optimistic target level: 145.27

Biogen Stock Forecast 01-22-2025.

Forecast target price for 01-22-2025: $143.48.
Positive dynamics for Biogen shares will prevail with possible volatility of 1.818%.
Pessimistic target level: 141.85
Optimistic target level: 144.47

Biogen Stock Forecast 01-23-2025.

Forecast target price for 01-23-2025: $139.31.
Negative dynamics for Biogen shares will prevail with possible volatility of 3.249%.
Pessimistic target level: 136.88
Optimistic target level: 141.48

Biogen Stock Forecast 01-24-2025.

Forecast target price for 01-24-2025: $140.69.
Positive dynamics for Biogen shares will prevail with possible volatility of 2.558%.
Pessimistic target level: 138.24
Optimistic target level: 141.87

Biogen Stock Forecast 01-25-2025.

Forecast target price for 01-25-2025: $139.55.
Negative dynamics for Biogen shares will prevail with possible volatility of 2.669%.
Pessimistic target level: 137.41
Optimistic target level: 141.18

Biogen Stock Forecast 01-26-2025.

Forecast target price for 01-26-2025: $138.96.
Negative dynamics for Biogen shares will prevail with possible volatility of 2.381%.
Pessimistic target level: 136.71
Optimistic target level: 140.05

BIIB (BIIB) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Feb. 152.02 147.46 164.79 10.52
Mar. 162.96 151.62 177.04 14.36
Apr. 170.59 161.38 184.51 12.54
May. 167.32 153.06 177.36 13.70
Jun. 173.14 162.13 187.68 13.62
Jul. 193.71 188.13 205.33 8.38
Aug. 189.99 179.27 204.81 12.47
Sep. 192.27 186.96 196.88 5.04
Oct. 200.57 195.28 216.46 9.78
Nov. 202.98 186.42 221.98 16.02
Dec. 196.89 182.48 206.34 11.56

Biogen forecast for this year


Biogen Stock Prediction for Feb 2025

An uptrend is forecast for this month with an optimal target price of $152.019. Pessimistic: $147.46. Optimistic: $164.79


Biogen Stock Prediction for Mar 2025

An uptrend is forecast for this month with an optimal target price of $162.964. Pessimistic: $151.62. Optimistic: $177.04


Biogen Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $170.591. Pessimistic: $161.38. Optimistic: $184.51


Biogen Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $167.316. Pessimistic: $153.06. Optimistic: $177.36


Biogen Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $173.138. Pessimistic: $162.13. Optimistic: $187.68


Biogen Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $193.707. Pessimistic: $188.13. Optimistic: $205.33


Biogen Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $189.988. Pessimistic: $179.27. Optimistic: $204.81


Biogen Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $192.268. Pessimistic: $186.96. Optimistic: $196.88


Biogen Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $200.574. Pessimistic: $195.28. Optimistic: $216.46


Biogen Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $202.981. Pessimistic: $186.42. Optimistic: $221.98


Biogen Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $196.891. Pessimistic: $182.48. Optimistic: $206.34



Biogen (BIIB) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 208.71 191.93 225.48 14.88
Feb 223.73 204.40 245.21 16.64
Mar 226.42 208.21 246.52 15.54
Apr 249.78 231.50 255.78 9.49
May 241.69 230.38 263.73 12.65
Jun 237.34 227.37 260.12 12.59
Jul 244.46 229.79 255.02 9.89
Aug 263.23 252.18 269.87 6.55
Sep 248.07 235.27 269.80 12.80
Oct 257.30 248.04 268.72 7.70
Nov 244.02 223.53 251.05 10.96
Dec 239.92 228.41 250.58 8.85

Biogen (BIIB) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 248.56 227.09 256.91 11.61
Feb 257.81 233.06 264.61 11.93
Mar 276.37 264.10 298.59 11.55
Apr 278.69 266.99 288.72 7.53
May 286.05 263.05 313.17 16.00
Jun 260.30 242.50 273.74 11.41
Jul 246.87 227.02 255.76 11.24
Aug 237.69 221.43 257.94 14.15
Sep 250.52 228.58 268.86 14.98
Oct 265.56 244.52 272.57 10.29
Nov 253.45 235.50 272.30 13.51
Dec 258.92 242.14 278.49 13.05

Biogen information and performance

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization: 20 480 807 000 $

Market capitalization of the Biogen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BIIB shares in the company outstanding by the market price of one share.

EBITDA: 2 885 000 000 $

EBITDA of Biogen is earnings before interest, income tax and depreciation of assets.

PE Ratio: 12.71

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 6.24

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 11.06

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.017
Quarterly Revenue Growth YOY: -0.025
Trailing PE: 12.71

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 8.26

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.647

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.09

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 145719000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.